A 2 Stage Trial of Lenalidomide (REV) in Asymptomatic Ovarian Cancer Patients With Increasing CA 125 in Late Relapse

NCT01111903 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer Recurrent

Interventions

DRUG: Lenalidomide

Sponsor

ARCAGY/ GINECO GROUP